N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-2-((11-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophtholazin-1-yl)methyl)benzoyl)piperazin-1-yl)-11-oxoundecyl)amino)acetamide

ID: ALA5186485

Chembl Id: CHEMBL5186485

PubChem CID: 168279253

Max Phase: Preclinical

Molecular Formula: C46H51FN8O8

Molecular Weight: 862.96

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1CCC(N2C(=O)c3cccc(NC(=O)CNCCCCCCCCCCC(=O)N4CCN(C(=O)c5cc(Cc6n[nH]c(=O)c7ccccc67)ccc5F)CC4)c3C2=O)C(=O)N1

Standard InChI:  InChI=1S/C46H51FN8O8/c47-34-18-17-29(27-36-30-12-8-9-13-31(30)42(59)52-51-36)26-33(34)44(61)54-24-22-53(23-25-54)40(58)16-7-5-3-1-2-4-6-10-21-48-28-39(57)49-35-15-11-14-32-41(35)46(63)55(45(32)62)37-19-20-38(56)50-43(37)60/h8-9,11-15,17-18,26,37,48H,1-7,10,16,19-25,27-28H2,(H,49,57)(H,52,59)(H,50,56,60)

Standard InChI Key:  XWKNVYAPUMCWRU-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5186485

    ---

Associated Targets(Human)

MDA-MB-436 (532 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAPAN-1 (772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-468 (9477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PARP1 Tclin Cereblon/PARP1 (186 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PARP2 Tclin CRBN/PARP2 (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PARP1 Tclin Poly [ADP-ribose] polymerase-1 (6206 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L02 (4864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H3122 (436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SW620/5-FU (115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 862.96Molecular Weight (Monoisotopic): 862.3814AlogP: 4.08#Rotatable Bonds: 18
Polar Surface Area: 211.05Molecular Species: BASEHBA: 10HBD: 4
#RO5 Violations: 1HBA (Lipinski): 16HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.95CX Basic pKa: 8.63CX LogP: 3.74CX LogD: 2.67
Aromatic Rings: 4Heavy Atoms: 63QED Weighted: 0.08Np Likeness Score: -1.06

References

1. Pu C, Wang S, Luo D, Liu Y, Ma X, Zhang H, Yu S, Lan S, Huang Q, Deng R, He X, Li R..  (2022)  Synthesis and biological evaluation of a tumor-selective degrader of PARP1.,  69  [PMID:35780655] [10.1016/j.bmc.2022.116908]

Source